toripalimab
junshi biosciences,coherus
['neotorch', 'toripalimab', 'nsclc', 'sclc']
dr. shun lu with an update on neotorch at #asco23. neoadjuvant + adjuvant toripalimab in resectable nsclc. updates from virtual plenary include more details on surgical disposition and efs breakdown by pdl1 strata. benefit seen across subgroups. more support for perioperative io. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo